BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19374934)

  • 21. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies.
    Duquesnoy RJ; Marrari M
    Curr Opin Organ Transplant; 2009 Aug; 14(4):403-9. PubMed ID: 19417654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA typing.
    Hutchinson JA
    Transplantation; 2015 Jan; 99(1):6-7. PubMed ID: 25525916
    [No Abstract]   [Full Text] [Related]  

  • 23. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients.
    Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G
    Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiallograft antibodies: relevance, detection, and monitoring.
    Leffell MS; Zachary AA
    Curr Opin Organ Transplant; 2010 Feb; 15(1):2-7. PubMed ID: 19898236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospects and limitations of post-transplantation alloantibody detection in renal transplantation.
    Böhmig GA; Bartel G; Regele H; Wahrmann M
    Hum Immunol; 2009 Aug; 70(8):640-4. PubMed ID: 19375475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians.
    Schinstock CA; Gandhi MJ; Stegall MD
    Transplantation; 2016 Aug; 100(8):1619-28. PubMed ID: 27140516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-HLA antibodies after rejection of HLA identical kidney transplants.
    Zafar MN; Terasaki PI; Naqvi SA; Rizvi SA
    Clin Transpl; 2006; ():421-6. PubMed ID: 18365399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies.
    Masson E; Stern M; Chabod J; Thévenin C; Gonin F; Rebibou JM; Tiberghien P
    J Heart Lung Transplant; 2007 Jun; 26(6):642-5. PubMed ID: 17543791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring and treating posttransplant human leukocyte antigen antibodies.
    Everly MJ; Terasaki PI
    Hum Immunol; 2009 Aug; 70(8):655-9. PubMed ID: 19375466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Caracterization of HLA allo-immunization and clinical impact in transfusion and organ transplantation].
    Delbos F; Cesbron A
    Transfus Clin Biol; 2017 Sep; 24(3):131-137. PubMed ID: 28757117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction: What we know about antibodies produced by transplant recipients against donor antigens not encoded by HLA genes.
    Stastny P
    Hum Immunol; 2013 Nov; 74(11):1421-4. PubMed ID: 23770305
    [No Abstract]   [Full Text] [Related]  

  • 32. Modulation of anti-HLA antibody production following renal transplantation in sensitised, immunoadsorbed patients.
    Bevan DJ; Carey BS; Vaughan RW; Fallon M; Higgins RM; Hendry BM; Bewick M
    Transplant Proc; 1997; 29(1-2):1448. PubMed ID: 9123375
    [No Abstract]   [Full Text] [Related]  

  • 33. Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation.
    Wong KL; Taner T; Smith BH; Kushwaha SS; Edwards BS; Gandhi MJ; Kremers WK; Daly RC; Pereira NL
    Circulation; 2017 Oct; 136(14):1350-1352. PubMed ID: 28972064
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
    Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S
    Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful kidney transplantation of immunized patients after desensitization with normal human polyclonal immunoglobulins.
    Glotz D; Haymann JP; Niaudet P; Lang P; Druet P; Bariety J
    Transplant Proc; 1995 Feb; 27(1):1038-9. PubMed ID: 7878793
    [No Abstract]   [Full Text] [Related]  

  • 36. Relevance of MICA and other non-HLA antibodies in clinical transplantation.
    Sumitran-Holgersson S
    Curr Opin Immunol; 2008 Oct; 20(5):607-13. PubMed ID: 18675346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of flow cytometric crossmatching in cardiac transplantation.
    Shenton BK; Glenville BE; Mitcheson AE; Coates E; Talbot D; Givan AL; Kirk A; Dark JH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1153-4. PubMed ID: 1989175
    [No Abstract]   [Full Text] [Related]  

  • 38. Review article: Luminex technology for HLA antibody detection in organ transplantation.
    Tait BD; Hudson F; Cantwell L; Brewin G; Holdsworth R; Bennett G; Jose M
    Nephrology (Carlton); 2009 Apr; 14(2):247-54. PubMed ID: 19207861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four short projects about antibodies, soluble CD30, and organ transplant rejection.
    Stastny P; Spells K; Rogers J; Zou Y; Lavingia B
    Clin Transpl; 2006; ():337-47. PubMed ID: 18365388
    [No Abstract]   [Full Text] [Related]  

  • 40. Human leukocyte antigen antibodies and chronic rejection: from association to causation.
    Terasaki PI; Cai J
    Transplantation; 2008 Aug; 86(3):377-83. PubMed ID: 18698239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.